Fuller & Thaler Asset Management Inc. bought a new position in Plexus Corp. (NASDAQ:PLXS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 158,150 shares of the technology company's stock, valued at approximately $24,747,000. Fuller & Thaler Asset Management Inc. owned 0.58% of Plexus at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Blue Trust Inc. lifted its holdings in Plexus by 12.1% during the 4th quarter. Blue Trust Inc. now owns 776 shares of the technology company's stock valued at $121,000 after purchasing an additional 84 shares during the last quarter. Nomura Asset Management Co. Ltd. boosted its holdings in shares of Plexus by 45.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company's stock worth $50,000 after acquiring an additional 100 shares in the last quarter. Tocqueville Asset Management L.P. grew its position in Plexus by 1.8% during the 4th quarter. Tocqueville Asset Management L.P. now owns 5,907 shares of the technology company's stock worth $924,000 after acquiring an additional 107 shares during the last quarter. GAMMA Investing LLC raised its position in Plexus by 17.2% in the 4th quarter. GAMMA Investing LLC now owns 891 shares of the technology company's stock valued at $139,000 after purchasing an additional 131 shares during the last quarter. Finally, TD Private Client Wealth LLC acquired a new stake in Plexus in the 4th quarter valued at about $28,000. 94.45% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on PLXS. Stifel Nicolaus set a $145.00 price target on Plexus in a research note on Thursday, April 24th. Needham & Company LLC reiterated a "buy" rating and set a $162.00 price target (down previously from $172.00) on shares of Plexus in a research report on Friday, April 25th. Finally, Benchmark reduced their price objective on shares of Plexus from $170.00 to $160.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $155.67.
View Our Latest Stock Analysis on Plexus
Insider Activity at Plexus
In related news, insider Michael J. Running sold 1,250 shares of the company's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $138.62, for a total value of $173,275.00. Following the transaction, the insider now owns 1,276 shares in the company, valued at approximately $176,879.12. This represents a 49.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Angelo Michael Ninivaggi, Jr. sold 3,423 shares of the company's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $145.14, for a total value of $496,814.22. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $4,281,775.14. This represents a 10.40 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 14,597 shares of company stock worth $2,066,030 in the last quarter. 1.76% of the stock is owned by insiders.
Plexus Stock Performance
Plexus stock traded down $3.73 during mid-day trading on Wednesday, hitting $122.08. 39,549 shares of the company's stock traded hands, compared to its average volume of 166,295. The stock has a market cap of $3.30 billion, a price-to-earnings ratio of 28.32 and a beta of 0.83. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The firm has a 50 day simple moving average of $125.17 and a two-hundred day simple moving average of $144.06. Plexus Corp. has a fifty-two week low of $99.79 and a fifty-two week high of $172.89.
Plexus (NASDAQ:PLXS - Get Free Report) last released its earnings results on Wednesday, April 23rd. The technology company reported $1.66 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.12. The firm had revenue of $980.17 million during the quarter, compared to the consensus estimate of $980.07 million. Plexus had a return on equity of 10.36% and a net margin of 3.03%. The company's revenue was up 1.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.94 EPS. On average, research analysts expect that Plexus Corp. will post 5.9 EPS for the current fiscal year.
Plexus Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.